Avandia Lawsuit Loans
Have a Settled Avandia Lawsuit But Need Cash Now?
TriMark Legal Funding provides post-settlement funding on settled Avandia lawsuits nationwide.
Legal Funding on Avandia Lawsuits
TriMark Legal Funding is one of America’s leading personal injury accident loan companies. We provide post-settlement funding (lawsuit loans) to injured plaintiffs with settled Avandia cases nationwide while they wait for their settlements to payout.
At TriMark Legal Funding, we offer non-recourse lawsuit funding cash advances to plaintiffs who are involved in either pending or settled legal claims, often in 24 hours or less.
Lawsuit loans are a discreet, sensible way to keep your head above water until your attorney has finished negotiating your lawsuit settlement.
Call and speak with one of our funding experts today.
Important Notice About Avandia Lawsuit Funding
This means that to qualify for funding consideration, you must have already signed your settlement agreement and know either
- The gross amount of your settlement OR
- The actual net amount you will be receiving after all deductions (attorney fees, case costs, medical liens, etc.)
If you have a settled Avandia lawsuit and would like to apply for settlement funding, please apply here.
How Lawsuit Loans Work
TriMark Legal Funding specializes in helping personal injury accident victims.
Our non-recourse legal funding is a simple 3-step process:
2. Review & Approval
Our team will work directly with your attorney to review your case. Approvals can happen as quickly as 1 hour after receipt of all required information.
3. Receive Cash
A funding agreement is sent via DocuSign. After signed copies are returned, your cash is sent to you by wire transfer or FedEx Overnight.
$0 UPFRONT FEES
NO CREDIT CHECK
Receive $1,000 to $250,000 in 4-24 hours after approval. No upfront or hidden fees and no hassles – EVER. You can relax while we work with your attorney to get you approved quickly.
AMERICA’S ORIGINAL LOWEST RATE GUARANTEE
On settled cases, we can offer capped, non-compounding rates of just over 2%.
We will match or beat any competitor’s contract rate.
NO WIN = NO PAY
Receive cash now but repay nothing until after your case settles. No monthly payments. Approval is based on the points and estimated net value of your case.
Avandia Lawsuit Funding
Are you currently waiting on an Avandia settlement because you suffered injuries or side effects from taking the prescription drug? Could you really use some of your future settlement money right now? TLF is one of the nation’s leading providers of Avandia settlement funding; pre-settlement and post-settlement.
What Is Avandia?
Studies have confirmed that the popular diabetic drug Avandia (a generic name is Rosiglitazone) has been linked to a number of serious and life-threatening cardiac risks and consequences.
Avandia (Rosiglitazone) is a member of class of drugs called Thiazolidinediones, or TZDs. It was approved by the FDA in 1999. It was released by GlaxoSmithKline (GSK) for the treatment of Type-2 diabetes as either a stand-alone medication or in combination with Metformin (Avandamet) or with Glimepiride (Avandaryl).
In 2007, more than eight years after Rosiglitazone was first introduced onto the market, a study conducted by Dr. Steven Nissen at the Cleveland Clinic made public the serious heart risks associated with the drug’s use. Dr. Nissen analyzed data that was handed over to the FDA in 2005. The data suggested that taking Avandia significantly increased the risk of heart attacks and heart-related deaths by over 40% and 60%, respectively. Dr. Nissen’s study was published in the New England Journal of Medicine (NEJM), a well-respected peer-reviewed medical journal.
Largely in response to this study, in 2007 the FDA reevaluated Avandia and confirmed Nissen’s findings. Nissen’s study further spurred a Senate Finance Committee investigation into the drug and its side effects.
The two-year investigation culminated in a 342-page report that concluded there was sufficient evidence to suggest that GSK was aware of the association between the drug and its cardiac risks several years prior to Nissen’s study becoming public. In fact, the evidence even suggested that GSK knew of the risks possibly as early as 1999, almost the same time the drug was approved by the FDA.
The Senate’s report further argued that the company had a duty to sufficiently warn patients and the FDA of its concerns because the report indicates “GSK executives intimidated independent physicians, focused on strategies to minimize findings that Avandia may increase cardiovascular risk, and sought ways to downplay findings that the rival drug ACTOS (Pioglitazone) might reduce cardiovascular risk.”
Avandia Side Effects
In addition to the increased risks of heart attack, stroke, and other cardiac events, some of the more common side effects include upper respiratory infections (cold-like symptoms); headaches; weight gain; back pain; anemia (low red blood cell count); bone fractures, hypoglycemia (low blood sugar), with symptoms of nervousness, sweating, intense hunger, trembling, weakness, or palpitations. Here is the full list of side effects.
Numerous lawsuits are currently pending against GSK, the manufacturer, alleging that it knew about severe adverse side effects and failed to disclose them to the FDA and the general public. Potentially serious side effects can include:
- Myocardial Infarction (Heart Attack)
- Congestive Heart Failure
- Edema, and Fluid Retention
- Cerebral Vascular Disease (Stroke)
- Other Myocardial Ischemic Related Events
The most significant side effect observed in clinical trials has been heart attacks and heart failures.
In studies involving over 14,000 patients, the results showed that users suffered 43% more heart attacks than those on a placebo.
Since its inception, the drug has been prescribed to millions of Americans and has generated as much as $3.2 billion per year in sales, as of 2006 and $1.19 billion as of 2009. Experts believe the drug is responsible for hundreds of thousands of cardiovascular problems in the U.S. from 1999 to 2009.
Is A Recall On The Horizon?
A public safety advisory was issued in 2007 to warn patients of the cardiovascular risks associated with the drug’s use. The FDA however, has refused to issue a recall, claiming that sufficient evidence as to the dangers versus the benefits of the drug does not exist.
As of July 2010, GSK has set aside $460 million to settle lawsuits filed by some 10,000 patients (an average of over $40 thousand per plaintiff) and thousands of more injured patients are gearing up to sue GSK over the drug.
Some of the Different Types of Funding We Provide
Archived cases are lawsuits that TriMark tracked or offered legal funding on at some point, but can no longer offer settlement funding on pending cases. While the majority of these lawsuits have been closed due to claim resolution and pre settlement funding is no longer available on them, some remain eligible for settled case funding.
Check the pages below for more information and to see if lawsuit funding is still available from TriMark.
More Defective Drugs…
Defective Medical Devices
Defective Products / Other
Apply For Avandia Lawsuit Settled Case Funding
To qualify for an Accutane lawsuit cash advance, you must have a settled Avandia lawsuit. Pending lawsuits are not eligible at this time.
To qualify, you must have an already signed Avandia settlement agreement which clearly shows either the gross amount of your settlement or the actual net amount you will be receiving after all deductions (attorney fees, case costs, medical liens, etc.) have been made.
If you have a settled Avandia lawsuit and need funding, either: